Search

everythinglearnresearchcommunity

for

Search:↓

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Treatments for melanin disorders exist, but more effective options needed.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Fibrinogen/LDL apheresis may improve speech perception in sudden hearing loss, especially for those with high fibrinogen and LDL levels.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Levetiracetam is widely used and generally well-tolerated for treating idiopathic generalized epilepsies, with tiredness as the main side effect.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

PRP more effective than minoxidil 5% for treating alopecia areata.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

New treatments are available for managing ingrown hair inflammation.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Acne is caused by increased sebum, abnormal skin shedding, bacteria, and inflammation, not dirt; treatments vary from creams to antibiotics or isotretinoin, with severe cases needing a dermatologist's care.

A rare skin disorder, Ichthyosis with confetti, has no cure but treatment focuses on managing symptoms with moisturizers.

Adolescents with severe alopecia incur significantly higher healthcare costs.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.